Divergent roles of superoxide and nitric oxide in liver ischemia and reperfusion injury

Journal of Clinical Biochemistry and Nutrition

Volumn 48, Issue 1, 2011, Pages 50-56

  Hines, Ian N ^a   Grisham, Matthew B ^b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Cytokines; Free radicals; NF B; Nitrite; Peroxynitrite

Indexed keywords

ANTIOXIDANT; CYTOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EXTRACELLULAR SUPEROXIDE DISMUTASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; REACTIVE OXYGEN METABOLITE; S NITROSOTHIOL; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CELL PROLIFERATION; CELL PROTECTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; HUMAN; LEUKOCYTE; LIPID PEROXIDATION; LIVER; LIVER CELL; LIVER CELL DAMAGE; LIVER ISCHEMIA; MEDIATOR; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHAGOCYTE; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

EID: 78650750620     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.11-016FR     Document Type: Review

References (66)

1. Urakami H, Abe Y, Grisham MB. Role of reactive metabolites of oxygen and nitrogen in partial liver transplantation: lessons learned from reduced-size liver ischaemia and reperfusion injury. Clin Exp Pharmacol Physiol 2007; 34: 912-919. (Pubitemid 47083960)
2. Urakami H, Grisham MB. Divergent roles of superoxide and nitric oxide in reduced-size liver ischemia and reperfusion injury: Implications for partial liver transplantation. Pathophysiology 2006; 13: 183-193.
3. Abe Y, Hines IN, Zibari G, and et al. Mouse model of liver ischemia and reperfusion injury: method for studying reactive oxygen and nitrogen metabolites in vivo. Free Radic Biol Med 2009; 46: 1-7.
4. Fan C, Zwacka RM, Engelhardt JF. Therapeutic approaches for ischemia/reperfusion injury in the liver. J Mol Med 1999; 77: 577-592. (Pubitemid 29479979)
5. Zwacka RM, Zhang Y, Zhou W, Halldorson J, Engelhardt JF. Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently of IkappaB degradation. Hepatology 1998; 28: 1022-1030. (Pubitemid 28450263)
6. Caldwell CC, Okaya T, Martignoni A, Husted T, Schuster R, Lentsch AB. Divergent functions of CD4+ T lymphocytes in acute liver inflammation and injury after ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 2005; 289: G969-G976. (Pubitemid 41532590)
7. Jaeschke H. Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol 2006; 290: G1083-G1088. (Pubitemid 43788288)
8. Lefer AM, Lefer DJ. Nitric oxide. II. Nitric oxide protects in intestinal inflammation. Am J Physiol 1999; 276: G572-G575.
9. Dezfulian C, Raat N, Shiva S, Gladwin MT. Role of the anion nitrite in ischemia-reperfusion cytoprotection and therapeutics. Cardiovasc Res 2007; 75: 327-338.
10. Vardanian AJ, Busuttil RW, Kupiec-Weglinski JW. Molecular mediators of liver ischemia and reperfusion injury: a brief review. Mol Med 2008; 14: 337-345.
11. Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 1991; 260: G355-G362.
12. Granger DN, Kubes P. Nitric oxide as antiinflammatory agent. Methods Enzymol 1996; 269: 434-442.
13. Abe Y, Hines I, Zibari G, Grisham MB. Hepatocellular protection by nitric oxide or nitrite in ischemia and reperfusion injury. Arch Biochem Biophys 2009; 484: 232-237.
14. Zwacka RM, Zhou W, Zhang Y, and et al. Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation. Nat Med 1998; 4: 698-704.
15. Hines IN, Hoffman JM, Scheerens H, and et al. Regulation of postischemic liver injury following different durations of ischemia. Am J Physiol Gastrointest Liver Physiol 2003; 284: G536-G545.
16. He SQ, Zhang YH, Venugopal SK, and et al. Delivery of antioxidative enzyme genes protects against ischemia/reperfusion-induced liver injury in mice. Liver Transpl 2006; 12: 1869-1879.
17. Jaeschke H. Reactive oxygen and ischemia/reperfusion injury of the liver. Chem Biol Interact 1991; 79: 115-136.
18. Moon KH, Hood BL, Mukhopadhyay P, and et al. Oxidative inactivation of key mitochondrial proteins leads to dysfunction and injury in hepatic ischemia reperfusion. Gastroenterology 2008; 135: 1344-1357.
19. Wink DA, Cook JA, Kim SY, and et al. Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates. Chemical aspects involved in the balance between oxidative and nitrosative stress. J Biol Chem 1997; 272: 11147-11151.
20. Wink DA, Vodovotz Y, Grisham MB, and et al. Antioxidant effects of nitric oxide. Methods Enzymol 1999; 301: 413-424.
21. Miles AM, Bohle DS, Glassbrenner PA, Hansert B, Wink DA, Grisham MB. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem 1996; 271: 40-47.
22. Jourd'heuil D, Mills L, Miles AM, Grisham MB. Effect of nitric oxide on hemoprotein-catalyzed oxidative reactions. Nitric Oxide 1998; 2: 37-44.
23. Baldus S, Heitzer T, Eiserich JP, and et al. Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free Radic Biol Med 2004; 37: 902-911.
24. Eiserich JP, Baldus S, Brennan ML, and et al. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 2002; 296: 2391-2194.
25. Grisham MB, Jourd'heuil D, Wink DA. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: Implications in inflammation. Am J Physiol 1999; 276: G315-G321.
26. Jha S, Calvert JW, Duranski MR, Ramachandran A, Lefer DJ. Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling. Am J Physiol Heart Circ Physiol 2008; 295: H801-H806.
27. Taniai H, Hines IN, Bharwani S, and et al. Susceptibility of murine periportal hepatocytes to hypoxia-reoxygenation: role for NO and Kupffer cell-derived oxidants. Hepatology 2004; 39: 1544-1552.
28. Gao B, Flores SC, McCord JM. A site-directed mutant of Cu,Zn-superoxide dismutase modeled after native extracellular superoxide dismutase. Biol Trace Elem Res 1995; 47: 95-100.
29. Gao B, Flores SC, Leff JA, Bose SK, McCord JM. Synthesis and anti-inflammatory activity of a chimeric recombinant superoxide dismutase: SOD2/3. Am J Physiol Lung Cell Mol Physiol 2003; 284: L917-L925.
30. Jaeschke H, Bautista AP, Spolarics Z, Spitzer JJ. Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after hepatic ischemia in rats. J Leukoc Biol 1992; 52: 377-382.
31. De Minicis, Bataller R, Brenner DA. NADPH oxidase in the liver: defensive, offensive, or fibrogenic? Gastroenterology 2006; 131: 272-275.
32. Jaeschke H. Kupffer cell-induced oxidant stress during hepatic ischemia-reperfusion: does the controversy continue? Hepatology 1999; 30: 1527-1528.
33. Madesh M, Hajnóczky G. VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release. J Cell Biol 2001; 155: 1003-1015.
34. Hines IN, Harada H, Flores S, Gao B, McCord JM, Grisham MB. Endothelial nitric oxide synthase protects the post-ischemic liver: potential interactions with superoxide. Biomed Pharmacother 2005; 59: 183-189.
35. Zhai Y, Qiao B, Shen XD, and et al. Evidence for the pivotal role of endogenous toll-like receptor 4 ligands in liver ischemia and reperfusion injury. Transplantation 2008; 85: 1016-1022.
36. Beutler BA. The role of tumor necrosis factor in health and disease. J Rheumatol 1999; 26 Suppl 57: 16-21.
37. Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 1997; 9: 240-246.
38. Schwabe RF, Brenner DA. Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 2006; 290: G583-G589.
39. Shin T, Kuboki S, Lentsch AB. Roles of nuclear factor-kappaB in post-ischemic liver. Hepatol Res 2008; 38: 429-440.
40. Harada H, Hines IN, Flores S, and et al. Role of NADPH oxidase-derived superoxide in reduced size liver ischemia and reperfusion injury. Arch Biochem Biophys 2004; 423: 103-108.
41. Janssen-Heininger YM, Poynter ME, Baeuerle PA. Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB. Free Radic Biol Med 2000; 28: 1317-1327.
42. Li N, Karin M. Is NF-kappaB the sensor of oxidative stress? FASEB J 1999; 13: 1137-1143.
43. Hayakawa M, Miyashita H, Sakamoto I, and et al. Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J 2003; 22: 3356-3366.
44. Lentsch AB, Kato A, Yoshidome H, McMasters KM, Edwards MJ. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 2000; 32: 169-173. (Pubitemid 30614647)
45. Gujral JS, Bucci TJ, Farhood A, Jaeschke H. Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis? Hepatology 2001; 33: 397-405.
46. Iimuro Y, Nishiura T, Hellerbrand C, and et al. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest 1998; 101: 802-811.
47. Teoh N, Field J, Sutton J, Farrell G. Dual role of tumor necrosis factor-alpha in hepatic ischemia-reperfusion injury: studies in tumor necrosis factor-alpha gene knockout mice. Hepatology 2004; 39: 412-421.
48. Luedde T, Assmus U, Wüstefeld T, and et al. Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. J Clin Invest 2005; 115: 849-859.
49. Beraza N, Lüdde T, Assmus U, Roskams T, Vander BS, Trautwein C. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury. Gastroenterology 2007; 132: 2504-2517.
50. Zwacka RM, Zhang Y, Halldorson J, Schlossberg H, Dudus L, Engelhardt JF. CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 1997; 100: 279-289.
51. Grisham MB, Granger DN, Lefer DJ. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Radic Biol Med 1998; 25: 404-433.
52. Kurose I, Wolf R, Grisham MB, Aw TY, Specian RD, Granger DN. Microvascular responses to inhibition of nitric oxide production. Role of active oxidants. Circ Res 1995; 76: 30-39.
53. Conner EM, Aiko S, Fernandez M, Battarbee HD, Gray L, Grisham MB. Duration of the hemodynamic effects of N(G)-nitro-L-arginine methyl ester in vivo. Nitric Oxide 2000; 4: 85-93.
54. Hines IN, Kawachi S, Harada H, and et al. Role of nitric oxide in liver ischemia and reperfusion injury. Mol Cell Biochem 2002; 234-235: 229-237. (Pubitemid 34777862)
55. Duranski MR, Elrod JW, Calvert JW, Bryan NS, Feelisch M, Lefer DJ. Genetic overexpression of eNOS attenuates hepatic ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2006; 291: H2980-H2986. (Pubitemid 44904099)
56. Li J, Billiar TR. Nitric Oxide. IV. Determinants of nitric oxide protection and toxicity in liver. Am J Physiol 1999; 276: G1069-G1073. (Pubitemid 29251903)
57. Katsumi H, Nishikawa M, Yamashita F, Hashida M. Prevention of hepatic ischemia/reperfusion injury by prolonged delivery of nitric oxide to the circulating blood in mice. Transplantation 2008; 85: 264-269. (Pubitemid 351156857)
58. Hines IN, Harada H, Bharwani S, Pavlick KP, Hoffman JM, Grisham MB. Enhanced post-ischemic liver injury in iNOS-deficient mice: a cautionary note. Biochem Biophys Res Commun 2001; 284: 972-976. (Pubitemid 32924743)
59. Kawachi S, Hines IN, Laroux FS, and et al. Nitric oxide synthase and post-ischemic liver injury. Biochem Biophys Res Commun 2000; 276: 851-854.
60. De Caterina, Libby P, Peng HB, and et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96: 60-68.
61. Marshall HE, Hess DT, Stamler JS. S-nitrosylation: physiological regulation of NF-kappaB. Proc Natl Acad Sci USA 2004; 101: 8841-8842.
62. Marshall HE, Stamler JS. Inhibition of NF-kappa B by S-nitrosylation. Biochemistry 2001; 40: 1688-1693.
63. Wood KC, Hsu LL, Gladwin MT. Sickle cell disease vasculopathy: A state of nitric oxide resistance. Free Radic Biol Med 2008; 44: 1506-1528.
64. Lefer DJ, Jones SP, Girod WG, and et al. Leukocyte-endothelial cell interactions in nitric oxide synthase- deficient mice. Am J Physiol 1999; 276: H1943-H1950. (Pubitemid 29323478)
65. Rogers H, III , Zibari GB, Roberts J, Turnage R, Lefer DJ. Nitric oxide attenuates ischaemia-reperfusion (I/R) injury in the diabetic liver. Clin Transplant 2004; 18: 7-11. (Pubitemid 39214090)
66. Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 2008; 7: 156-167. (Pubitemid 351194063)